In contrast however, genetic variants which lead to higher circulating concentrations of IL‐6 receptors (IL‐6R) (and consequently less IL‐6 cell signalling and lower circulating CRP) appear protective against CHD (IL6R Mendelian randomisation Consortium, 2012; Sarwar et al.,2012). Here, CRP is linked to coronary artery disorder.